BTX Company Profile and Key Details

NYSE : BTX

BlackRock Technology and Private Equity Term Trust

$7.31

-0.045-0.61%

Open: 3:28 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

BlackRock Technology and Private Equity Term Trust (BTX) stock declined over -0.61%, trading at $7.31 on NYSE, down from the previous close of $7.35. The stock opened at $7.34, fluctuating between $7.28 and $7.37 in the recent session.

Stock Snapshot

7.35

Prev. Close

852.57M

Market Cap

7.28

Day Low

19.22

P/E Ratio

0.38

EPS (TTM)

N/A

Cash Flow per Share

7.34

Open

116.71M

Number of Shares

7.37

Day High

1.44%

Free Float in %

N/A

Book Value

836.6K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 14, 2026	7.41	7.47	7.37	7.46	702.07K
Apr 13, 2026	7.25	7.35	7.20	7.35	729.88K
Apr 10, 2026	7.17	7.25	7.14	7.23	879.18K
Apr 09, 2026	6.92	7.10	6.92	7.10	1.09M
Apr 08, 2026	6.93	6.98	6.84	6.90	619.06K
Apr 07, 2026	6.68	6.76	6.63	6.70	1.03M
Apr 06, 2026	6.77	6.78	6.69	6.75	512.86K
Apr 02, 2026	6.63	6.79	6.55	6.73	511.98K
Apr 01, 2026	6.65	6.77	6.62	6.76	643.12K
Mar 31, 2026	6.38	6.60	6.35	6.60	804.24K
Mar 30, 2026	6.49	6.49	6.25	6.29	608.99K
Mar 27, 2026	6.52	6.60	6.38	6.42	667.69K
Mar 25, 2026	6.73	6.83	6.58	6.76	639.61K
Mar 24, 2026	6.49	6.70	6.49	6.65	898.64K
Mar 23, 2026	6.48	6.65	6.45	6.60	693.24K
Mar 20, 2026	6.58	6.58	6.37	6.38	837.92K
Mar 19, 2026	6.41	6.56	6.36	6.53	448.01K
Mar 18, 2026	6.45	6.54	6.45	6.49	589.94K
Mar 17, 2026	6.40	6.51	6.40	6.49	454.13K
Mar 16, 2026	6.30	6.44	6.25	6.39	648.33K

Contact Details

San Diego, CA 92121

United States

https://www.blackrock.com 212 582 1199

About Company

BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.

Stock Peers

MANE

3.63+5.09%

Veradermics, Incorporated$74.99 AMAM

0.02+0.07%

Ambrx Biopharma Inc.$28.00 EVMN

-0.38-1.41%

Evommune, Inc.$26.63 ANRO

0.07+0.27%

Alto Neuroscience, Inc.$25.82 RCUS

0.62+2.77%

Arcus Biosciences, Inc.$23.01 BHVN

0.32+3.16%

Biohaven Ltd.$10.44 DNA

1.04+15.57%

Ginkgo Bioworks Holdings, Inc.$7.72 NUVB

0.15+3.19%

Nuvation Bio Inc.$4.85 ADCT

0.05+1.31%

ADC Therapeutics S.A.$3.86 ANVS

0.07+4.22%

Annovis Bio, Inc.$1.73

Company Overview

BlackRock Technology and Private Equity Term Trust (NYSE:BTX) closed at $7.30 USD, losing -$0.04 (-0.61%) from the previous close of $7.35. The stock is currently within 5% of its 52-week high $5.63 and $7.50. With a market capitalization of about $852.57 million, BlackRock Technology and Private Equity Term Trust is classified as a small-cap and shows market-like volatility (beta ~1.27). Key stats such as the average daily volume over the past year has been around 770.51 thousand shares, in line with its 52-week average. Headquartered in San Diego, CA, BlackRock Technology and Private Equity Term Trust operates in the Healthcare sector and the Biotechnology industry. BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history.

Technical Performance

BTX has shown mixed momentum, losing -1.47% over the past week and 1.98% over the past quarter, though year-to-date performance is up 1.52%. Short-term trend indicators are bullishly aligned (SMA20 0.13%, SMA50 -1.09%, SMA200 -4.46%). The stock’s 14-day RSI is 48.5 (neutral), while the ATR of 0.15 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -12.07% below its high and over 29.31% above its low. Average 10-day trading volume of 795.46 thousand shares is in line with the 3-month average of 816.08 thousand, indicating normal recent market interest.

Valuation Metrics

BlackRock Technology and Private Equity Term Trust trades at a P/E ratio of 45.08, slightly above the S&P 500 average, with a price-to-sales ratio of 21.38 and a price-to-book ratio of 1.76 suggesting the stock is closer to book value. The P/FCF stands at 0.99, also below market averages.

Dividend & Fair Value

BlackRock Technology and Private Equity Term Trust last paid a dividend of 0.63 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.45. This means the shares are trading above this model’s fair value.

Financial & Profitability Overview

Over the trailing twelve months, BlackRock Technology and Private Equity Term Trust has not generated any revenue.
On valuation metrics, BlackRock Technology and Private Equity Term Trust trades at a P/E of 45.08, P/S of 21.38 and P/B of 1.76. Liquidity is tight, with a current ratio of 0.13 and quick ratio of 0.13. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 8.42 days.

Price Forecast & Outlook

Our AI price prediction model suggests that BlackRock Technology and Private Equity Term Trust stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -13.54%, with price expected at $6.45 by February 27, 2026, within a range of $6.32 to $6.59 3-Month Outlook: Projected rise of 5.09%, reaching $7.84 by May 14, 2026, with a range of $7.78 to $7.89. 1-Year Outlook: Projected gain of 223.73%, with price at $24.15 by February 12, 2027, within a range of $24.11 to $24.19.

Key Takeaways

BlackRock Technology and Private Equity Term Trust (NYSE:BTX) shares are flat 1.52% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows BlackRock Technology and Private Equity Term Trust trading at a premium to the broader market with a P/E of 45.08. Our AI forecast model points to short-term weakness (-13.54% over two weeks), a medium-term rise (5.09% over three months), and a longer-term gain (223.73% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current BlackRock Technology and Private Equity Term Trust (BTX) stock price?

BlackRock Technology and Private Equity Term Trust (NYSE: BTX) stock price is $7.31 in the last trading session. During the trading session, BTX stock reached the peak price of $7.37 while $7.28 was the lowest point it dropped to. The percentage change in BTX stock occurred in the recent session was -0.61% while the dollar amount for the price change in BTX stock was - $0.05.

BTX's industry and sector of operation?

The NYSE listed BTX is part of Biotechnology industry that operates in the broader Healthcare sector. BlackRock Technology and Private Equity Term Trust designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BTX?

No Data

How BTX did perform over past 52-week?

BTX's closing price is 32.5% higher than its 52-week low of $5.63 where as its distance from 52-week high of $7.50 is -0.53%.

How many employees does BTX have?

Number of BTX employees currently stands at 0.

Link for BTX official website?

Official Website of BTX is: https://www.blackrock.com

How do I contact BTX?

BTX could be contacted at phone 212 582 1199 and can also be accessed through its website. BTX operates from 10355 Science Center Drive, San Diego, CA 92121, United States.

How many shares of BTX are traded daily?

BTX stock volume for the day was 836.6K shares. The average number of BTX shares traded daily for last 3 months was 770.51K.

What is the market cap of BTX currently?

The market value of BTX currently stands at $852.57M with its latest stock price at $7.31 and 116.71M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	0
Beta	1.32
Sales or Revenue	N/A
5Y Sales Change%	1.388%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

BTX Company Profile and Key Details

BlackRock Technology and Private Equity Term Trust

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Stock Snapshot

Technical Performance

Financial & Profitability Overview

Company Overview

Dividend & Fair Value

Key Takeaways

Price Forecast & Outlook

Valuation Metrics